Cargando…
Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time u...
Autores principales: | Schaarschmidt, Marthe-Lisa, Kromer, Christian, Herr, Raphael, Schmieder, Astrid, Sonntag, Diana, Goerdt, Sergij, Peitsch, Wiebke K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669171/ https://www.ncbi.nlm.nih.gov/pubmed/26633680 http://dx.doi.org/10.1371/journal.pone.0144335 |
Ejemplares similares
-
Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment
por: Kromer, Christian, et al.
Publicado: (2015) -
Analyzing the value of an educational program for psoriasis patients: a prospective controlled pilot study
por: Bubak, Corinna, et al.
Publicado: (2019) -
Biologicals and small molecules in psoriasis: A systematic review of economic evaluations
por: Kromer, Christian, et al.
Publicado: (2018) -
Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology
por: Umar, Nasir, et al.
Publicado: (2012) -
Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study
por: Kromer, Christian, et al.
Publicado: (2019)